Guardant Health, Inc.
GH
You’ve read what changed. Here’s whether the market is confirming it.
Jodie situation report
Guardant Health, Inc.'s current read is isolated; its market group is not confirming.
The latest filing evidence is available. 0 of 9 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 19 directly disclosed connections are confirming.
- Revenue increased 48.3% versus the comparable filing period.
- The operating loss widened by 10.3M.
- GH's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if GH's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind GH
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
AMGNAmgen Inc.supplierFeb 19, 2026 ▾
“The MHLW additionally granted regulatory approval of the Guardant360 CDx liquid biopsy test as a companion diagnostic for identifying patients with metastatic NSCL cancer who may benefit from treatment with LUMAKRASTM (sotorasib), a KRAS G12C inhibitor develo…”
PANWPalo Alto Networks, Inc.partnerOct 29, 2025 ▾
“In addition, our Redwood City, San Diego and Palo Alto, California laboratories are currently operated as centers for our research and technology development, and our Palo Alto laboratory is also CLIA licensed.”
Depended on by
BLLNBillionToOne, Inc.competitorMar 11, 2026 ▾
“In the oncology market, our main competitors for our therapy selection and response monitoring tests include Caris Life Sciences, Inc., Foundation Medicine, Inc., which was acquired by Roche Holdings, Inc., Guardant Health, Inc., NeoGenomics Laboratories, Inc…”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 20 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
GH is currently a Follower in the organic co-movement group Speculative Growth. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.